IB Acquisition Corp.IBAC

NasdaqHealthcareServices-Commercial Physical & Biological Research
Price (close)
$11.30
Market cap
$48.0M
P/E
—
Revenue (TTM)
—
Net income
-$399,569
Dividend yield
—
1-year total return
6.6%
Net margin
—
Revenue growth
—
Debt / equity
—

What IB Acquisition Corp. does.

are a blank check company formed under the laws of the State of Delaware on July 7, 2020 and which converted to a Nevada corporation

on September 21, 2023. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization

or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination.

Revenue and profit, by fiscal year.

Fiscal year2022202320242025
Net income—-$6,844$1.9M$3.4M

More on IBAC.

Figures from IB Acquisition Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.